STEVEN WILLIAMS: Open Payments
NPI 1134771025 · WINTER GARDEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 37 payments from 10 companies in 2025. Trend: 2023 $156 · 2024 $40 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $203 |
| Novo Nordisk Inc | 7 | $153 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| Exact Sciences Corporation | 3 | $72 |
| PFIZER INC. | 4 | $72 |
| Amgen Inc. | 4 | $64 |
| GlaxoSmithKline, LLC. | 1 | $35 |
| Lilly USA, LLC | 2 | $32 |
| Dynavax Technologies Corporation | 1 | $26 |
| Astellas Pharma US Inc | 1 | $16 |
Products named: UBRELVY, The Cologuard Plus Collection Kit, AIRSUPRA, Ozempic, VRAYLAR, OTEZLA, PREVNAR 20, QULIPTA.
Industry payments across FL — which companies pay providers there.
